As the number of RSV infections rises, two recent studies found that protecting babies against the disease prevented ...

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and ...

The CDC and the American Academy of Pediatrics recommend the RSV monoclonal antibody treatment Beyfortus for babies under 8 ...

Scientists have uncovered strong evidence that infection with RSV in the first months of life can significantly raise the ...

Shawn Johnson East, Olympic gymnastics gold medalist, said her son was hospitalized with RSV at age 1, prompting her mission ...

Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory infections among infants, particularly ...

Infants who receive nirsevimab may have a lower risk for hospitalisation for RSV-related lower respiratory tract infection ...

How effective is nirsevimab at preventing respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD), ...

Globally, RSV causes millions of respiratory infections each year and is responsible for a large proportion of ...

New Centers for Disease Control and Prevention data is showing that newly released RSV vaccines are highly effective at keeping infants from becoming hospitalized. The CDC says nirsevimab was 90% ...

As families and friends gather for holiday celebrations, respiratory syncytial virus (RSV), also makes its return.

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...